Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

Clinical trial NCT02159859 · COMPLETED

Trial details

NCT number: NCT02159859
Sponsor: Corewell Health East
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2014-12-01
Primary completion: 2016-04-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.